IOmx Therapeutics
Michail Maraslis has worked for a number of organizations since 2017. In 2017, they were a Research Assistant at Universität Konstanz. In 2018, they were a Research Intern at both Sahlgrenska Academy at University of Gothenburg and University of Bergen/Haukeland University Hospital. In 2019, they completed a Master Thesis at Biotechnologie Institut Thurgau an der Universität Konstanz. In 2020, they were a Research Assistant at the same organization. Currently, they are a Research Associate II - Preclinical Pharmacology & Biomarker Development and Research Associate - Preclinical Pharmacology & Biomarker Development at iOmx Therapeutics AG.
Michail Maraslis completed a Bachelor of Science (BS) in Biological Sciences at the University of Konstanz between 2013 and 2016. Michail then went on to pursue a Master of Science (MS) in Biological Sciences, Disease Biology at the same university, graduating in 2020. In 2017-2018, they also completed an MS in Molecular Biology at the University of Gothenburg. Most recently, they completed Free Studies in Bioentrepreneurship at Karolinska Institutet in 2020.
IOmx Therapeutics
1 followers
iOmx Therapeutics focuses on the development of first-in-class cancer therapeutics.